NICE Confirms English Funding For Three COVID-19 Drugs, But Rejects Four Others

 
• By Ian Schofield

There is good news for medicines from Pfizer, GSK and Roche, but MSD, Gilead and AstraZeneca have all appealed against NICE’s decision not to recommend their products for treating COVID-19.

Coronavirus_Cells
Three COVID-19 therapies have been recommended for funding on the NHS • Source: Shutterstock

More from Europe

More from Geography